Related Experiment Video
Updated: Aug 8, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thrombolysis: past, present, and future
1University Hospital, Nottingham NG7 2UH, UK. d.gray@nottingham.ac.uk
Insights
Management of myocardial infarction (heart attack) has improved with clot-dissolving treatments. While angioplasty is preferred, thrombolysis remains crucial due to its wide availability and lower cost, especially in community settings.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Trials
Background:
- Myocardial infarction (MI) management has evolved significantly.
- Understanding of disease processes and clinical trials led to improved mortality rates.
- Both chemical (thrombolysis) and mechanical (angioplasty) clot dissolution strategies have been developed.
Purpose of the Study:
- To compare the efficacy of thrombolysis versus angioplasty in managing myocardial infarction.
- To discuss current treatment guidelines and their practical implementation challenges.
- To evaluate the role of community thrombolysis in MI care.
Main Methods:
- Meta-analysis comparing thrombolysis and angioplasty.
- Review of European Society of Cardiology guidelines.
- Discussion of logistical and cost factors for treatment implementation.
Main Results:
- Meta-analysis marginally favored angioplasty over thrombolysis.
- Primary angioplasty is the guideline-recommended option.
- Limited availability of primary angioplasty in UK "heart attack centres" necessitates continued use of thrombolysis.
Conclusions:
- Thrombolysis remains a vital treatment option for myocardial infarction due to its accessibility and cost-effectiveness.
- Community thrombolysis offers a valuable alternative for patients unable or unwilling to undergo immediate angioplasty.
- Balancing guideline recommendations with resource availability is key for optimal MI patient care.
Abstract:
Management of myocardial infarction evolved because of understanding of underlying disease processes and clinical trials of "chemical" and "mechanical" clot dissolution that reduced in-hospital mortality. Meta-analysis comparing these treatment strategies marginally favours angioplasty. Current European Society of Cardiology guidelines propose primary angioplasty as the preferred therapeutic option but few units in the UK can offer angioplasty on demand as a designated "heart attack centre". Thrombolysis will continue as it is widely available and training needs and costs less than angioplasty. Community thrombolysis should be made available for those patients who do not wish for such aggressive intervention or as a prelude to transfer time to a heart attack centre distant from a triage hospital.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis

